Nodal Marginal Zone Lymphoma: Impersonalized Medicine THE TRAVERSE-GLEHEN ET AL ARTICLE REVIEWED

被引：0
作者：
Lai, Catherine [1 ]
Roschewski, Mark [2 ]
机构：
[1] NCI, Med Oncol Clin Res Unit, Bethesda, MD 20892 USA
[2] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
来源：
ONCOLOGY-NEW YORK | 2012年 / 26卷 / 01期
关键词：
B-CELL LYMPHOMA; FOLLICULAR LYMPHOMA; RITUXIMAB; THERAPY; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：104 / +
页数：3
相关论文
共 19 条
  • [1] [Anonymous], ASH ANN M
  • [2] A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas
    Brown, Jennifer R.
    Friedberg, Jonathan W.
    Feng, Yang
    Scofield, Sarah
    Phillips, Kimberly
    Dal Cin, Paola
    Joyce, Robin
    Takvorian, Ronald W.
    Fisher, David C.
    Fisher, Richard I.
    Liesveld, Jane
    Marquis, Diana
    Neuberg, Donna
    Freedman, Arnold S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) : 741 - 748
  • [3] The microenvironment in mature B-cell malignancies: a target for new treatment strategies
    Burger, Jan A.
    Ghia, Paolo
    Rosenwald, Andreas
    Caligaris-Cappio, Federico
    [J]. BLOOD, 2009, 114 (16) : 3367 - 3375
  • [4] Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
    Chao, Mark P.
    Tang, Chad
    Pachynski, Russell K.
    Chin, Robert
    Majeti, Ravindra
    Weissman, Irving L.
    [J]. BLOOD, 2011, 118 (18) : 4890 - 4901
  • [5] Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
    Conconi, A
    Martinelli, G
    Thiéblemont, C
    Ferreri, AJM
    Devizzi, L
    Peccatori, F
    Ponzoni, M
    Pedrinis, E
    Dell'Oro, S
    Pruneri, G
    Filipazzi, V
    Dietrich, PY
    Gianni, AM
    Coiffier, B
    Cavalli, F
    Zucca, E
    [J]. BLOOD, 2003, 102 (08) : 2741 - 2745
  • [6] Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
    Friedberg, Jonathan W.
    Taylor, Michael D.
    Cerhan, James R.
    Flowers, Christopher R.
    Dillon, Hildy
    Farber, Charles M.
    Rogers, Eric S.
    Hainsworth, John D.
    Wong, Elaine K.
    Vose, Julie M.
    Zelenetz, Andrew D.
    Link, Brian K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1202 - 1208
  • [7] How I treat indolent lymphoma
    Gribben, John G.
    [J]. BLOOD, 2007, 109 (11) : 4617 - 4626
  • [8] The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
    Herishanu, Yair
    Perez-Galan, Patricia
    Liu, Delong
    Biancotto, Angelique
    Pittaluga, Stefania
    Vire, Berengere
    Gibellini, Federica
    Njuguna, Ndegwa
    Lee, Elinor
    Stennett, Lawrence
    Raghavachari, Nalini
    Liu, Poching
    McCoy, J. Philip
    Raffeld, Mark
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Sherry, Richard
    Arthur, Diane C.
    Maric, Irina
    White, Therese
    Marti, Gerald E.
    Munson, Peter
    Wilson, Wyndham H.
    Wiestner, Adrian
    [J]. BLOOD, 2011, 117 (02) : 563 - 574
  • [9] Kahl Brad, 2008, Hematology Am Soc Hematol Educ Program, P359, DOI 10.1182/asheducation-2008.1.359
  • [10] LaCasce AS, 2008, J CLIN ONCOL, V26, P1
12